Response of a radioresistant human melanoma cell line along the proton spread-out Bragg peak

International Journal of Radiation Biology

Volumn 86, Issue 9, 2010, Pages 742-751

  Petrović, Ivan ^a   Ristić Fira, Aleksandra ^a   Todorović, Danijela ^a   Korićanac, Lela ^a   Valastro, Lucia ^b   Cirrone, Pablo ^b   Cuttone, Giacomo ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b INFN SEZIONE DI CATANIA   (Italy)

Author keywords

cell cycle analyses; LET, HTB140 melanoma cells; proliferation; proton spread out Bragg peak; survival

Indexed keywords

PROTON;

CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; HUMAN; LINEAR ENERGY TRANSFER; MELANOMA; PATHOLOGY; RADIATION DOSE; RADIATION RESPONSE; RELATIVE BIOLOGIC EFFECTIVENESS; TUMOR CELL LINE;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; LINEAR ENERGY TRANSFER; MELANOMA; PROTONS; RADIATION TOLERANCE; RELATIVE BIOLOGICAL EFFECTIVENESS;

EID: 77956285946     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2010.481322     Document Type: Article

References (43)

1. Beauchesne PD, Bertrand S, Branche R, Linke SP, Revel R, Doré JF, Pedeux RM. 2003. Human malignant glioma cell lines are sensitive to low radiation doses. International Journal of Cancer 105:33-40.
2. Belli M, Bettega D, Calzolari P, Cera F, Cherubini R, Dalla Vecchia M, Durante M, Favaretto S, Gialanella G, Grossi G, Marchesini R, Moschini G, Piazzola A, Poli G, Pugliese M, Sapora O, Scampoli P, Simone G, Sorrentino E, Tabocchini MA, Tallone L, Tiveron P. 2000. Inactivation of human normal and tumour cells irradiated with low energy protons. International Journal of Radiation Biology 76:831-839.
3. Belli M, Cherubini R, Finotto S, Moschini G, Sapora O, Simone G, Tabocchini MA. 1989. RBE-LET relationship for the survival of V79 cells irradiated with low energy protons. International Journal of Radiation Biology 55:93-104.
4. Bettega D, Calzolari P, Chauvel P, Courdi A, Herault J, Iborra N, Marchesini R, Massariello P, Poli GL, Tallone L. 2000. Radiobiological studies on the 65 MeV therapeutic proton beam at Nice using human tumour cells. International Journal of Radiation Biology 76:1297-1303.
5. Cirrone G.A.P., Cuttone G., Lojacono PA, Lo Nigro S, Mongelli V, Patti V, Privitera G., Raffaele L, Rifuggiato D, Sabini MG, Salamone V, Spatola C, Valastro LM. 2004. A 62 MeV proton beam for the treatment of ocular melanoma at Laboratori Nazionali del Sud-INFN. IEEE Transactions on Nuclear Science 51:860-865.
6. Courdi A, Brassart N, Herault J, Chauvel P. 1994. The depthdependent radiation response of human melanoma cells exposed to 65 MeV protons. The British Journal of Radiology 67:800-804.
7. Courdi A, Caujolle J-P, Grange J-D, Diallo-Rosier L, Sahel J, Bacin F, Zur C, Gastaud P, Iborra-Brassart N, Herault J, Chauvel P. 1999. Results of proton therapy of uveal melanomas treated in Nice. International Journal of Radiation Oncology, Biology, Physics 45:5-11.
8. De Nardo L, Moro D, Colautti P, Conte V, Tornielli G, Cuttone G. 2004a. Microdosimetric investigation at the therapeutic proton beam facility of CATANA. Radiation Protection Dosimetry 110:681-686.
9. De Nardo L, Cesari V, Iborra N, Conte V, Colautti P, Hérault J, Tornielli G, Chauvel P. 2004b. Microdosimetric assessment of Nice therapeutic proton beam biological quality. Physica Medica 20:71-77.
10. Egger E, Schalenbourg A, Zografos L, Bercher L, Böehringer T, Chamot L, Goitein G. 2001. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. International Journal of Radiation Oncology, Biology, Physics 51:138-147.
11. Egger E, Zografos L, Schalenbourg A, Beati D, Böehringer T, Chamot L, Goitein G. 2003. Eye retention after proton beam radiotherapy for uveal melanoma. International Journal of Radiation Oncology, Biology, Physics 55:867-880.
12. GEANT4. 1998. GEANT4: Detector Description and Simulation Tool, CERN Program Library.
13. Green LM, Murray DK, Tran DT, Bant AM, Kazarians G, Moyers MF, Nelson GA. 2001. Response of thyroid follicular cells to gamma irradiation compared to proton irradiation. I. Initial characterization of DNA damage, micronucleus formation, apoptosis cell survival, and cell cycle phase redistribution. Radiation Research 155:32-42.
14. International Atomic Energy Agency (IAEA). 2000. IAEA Technical Report Series No. 398. Absorbed dose determination in external beam radiotherapy: An international code of practice for dosimetry based on standards of absorbed dose to water. Vienna: IAEA. pp 135-150.
15. International Commission on Radiation Units (ICRU) Report 49. 1993. Stopping powers and ranges for protons and a particles. Bethesda, MD: ICRU.
16. Janni JF. 1982. Proton range-energy tables, 1 KeV-10 GeV, Part 1. Atomic Data and Nuclear Data Tables 27:147-339.
17. Joiner MC, Marples B, Johns H. 1993. The response of tissues to very low doses per fraction: A reflection of induced repair? Recent Results in Cancer Research 130:27-40.
18. Jungnelius U, Ringborg U, Aamdal S, Mattsson J, Stierner U, Ingvar C, Malmström P, Andersson R, Karlsson M, Willman K, Wist E, Bjelkengren G, Westberg R. 1998. Dacarbazinevindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial. European Journal of Cancer 34:1368-1374.
19. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. 1992. Wildtype p53 is a cell cycle checkpoint determinant following irradiation. Proceedings of National Academy of Sciences of the USA 89:7491-7495.
20. Kumala S, Niemiec P, Widel M, Hancock R, Rzeszowska-Wolny J. 2003. Apoptosis and clonogenic survival in three tumour cell lines exposed to gamma rays or chemical genotoxic agents. Cellular and Molecular Biology Letters 8:655-665.
21. Lambin P, Malaise EP, Joiner MC. 1996. Might intrinsic radioresistance of human tumor cells be induced by radiation. International Journal of Radiation Biology 69:279-290.
22. Loeffler JS, Smith AR, Suit HD. 1998. The potential role of proton beams in radiation oncology. Seminars in Oncology 24:686-695.
23. Marples B, JoinerMC. 1993. The response of Chinese hamster V79 cells to low radiation doses: Evidence of enhanced sensitivity of the whole cell population. Radiation Research 133:41-51.
24. Marples B, Joiner MC. 2000. Modification of survival by DNA repair modifiers: A probable explanation for the phenomenon of increased radioresistance. International Journal of Radiation Biology 76:305-312.
25. Marshall ES, Matthews JHL, Shaw JHF, Nixon J, Tumewu P, Finlay GJ, Holdaway KM, Baguley BC. 1994. Radiosensitivity of new and established human melanoma cell lines: Comparison of [3H]thymidine incorporation and soft agar clonogenic assays. European Journal of Cancer 30A:1370-1376.
26. Matsubara S, Ohara H, Hiraoka T, Koike S, Ando K, Yamaguchi H, Kuwabara Y, Hoshina M, Suzuki S. 1990. Chromosome aberration frequencies produced by a 70 MeV proton beam. Radiation Research 123:182-191.
27. McKay MJ, Kefford RF. 1995. The spectrum of in vitro rediosensitivity in four human melanoma cell lines is not accounted for by different induction or rejoining of DNA double strand breaks. International Journal of Radiation Oncology Biology Physics 31:345-352.
28. Mirzaie-Joniani H, Eriksson D, Sheikhovaezin A, Johansson A, Löfroth P-O, Johansson L, Stigbrand T. 2002. Apoptosis induced by low-dose and low-dose-rate radiation. Cancer 94:1210-1214.
29. Miyato Y, Ando K. 2004. Apoptosis of human melanoma cells by a combination of lonidamine and radiation. Journal of Radiation Research 45:189-194.
30. Paganetti H, Schmitz Th. 1996. The influence of the beam modulation technique on dose and RBE in proton radiation therapy. Physics in Medicine and Biology 41:1649-1663.
31. Paganetti H. 1998. Calculation of the spatial variation of relative biological effectiveness in a therapeutic proton field for eye treatment. Physics in Medicine and Biology 43:2147-2157.
32. Paganetti H. 2002. Nuclear interactions in proton therapy: Dose and relative biological effect distributions originating from primary and secondary particles. Physics in Medicine and Biology 47:747-764.
33. Passagne I, Evrard A, Winum J-Y, Depeille P, Cuq P, Montero J-L, Cupissol D, Vian L. 2003. Cytotoxicity, DNA damage, and apoptosis induced by new fotemustine analogs on human melanoma cells in relation to O6-methylguanine DNAmethyltransferase expression. Journal of Pharmacology and Experimental Therapeutics 307:816-823.
34. Petrović I, Ristić-Fira A, Todorović D, Valastro L, Cirrone GAP, Cuttone G. 2006. Radiobiological analysis of human melanoma cells on the 62 MeV CATANA proton beam. International Journal of Radiation Biology 82:251-265.
35. Ristić-Fira AM, Petrović IM, Korićanac LB, Valastro LM, Privitera G, Cuttone G. 2008. Assessment of the inhibitory effects of different radiation qualities or chemotherapeutic agents on a human melanoma cell line. Physica Medica 24:187-195.
36. Robertson JB, Williams JR, Schmidt RA, Little JB, Flynn DF, Suit HD. 1975. Radiobiological studies of a high-energy modulated proton beam utilizing cultured mammalian cells. Cancer 35:1664-1677.
37. Rudoltz MS, Kao G, Blank KR, Muschel RJ, McKenna WG. 1996. Molecular biology of the cell cycle: Potential for therapeutic applications in radiation oncology. Seminars in Radiation Oncology 6:284-294.
38. Schorl C, Sedivy JM. 2007. Analysis of the cell cycle phases and progression in cultured mammalian cells. Methods 41:143-150.
39. Smalley KSM, Eisen TG. 2002. Differentiation of melanoma cells through p38 MAP kinase is associated with decreased retinoblastoma protein phosphorylation and cell cycle arrest. Melanoma Research 12:187-192.
40. Tang JT, Inoue T, Yamazaki H, Fukushima S, Fournier- Bidoz N, Koizumi M, Ozekj S, Hatanaka K. 1997. Comparison of radiobiological effective depths in 65 MeV modulated proton beams. British Journal of Cancer 76:220-225.
41. Tsoulou E, Baggio L, Cherubini R, Kalfas CA. 2001. Radiosensitivity of V79 cells after alpha particle radiation at low doses. Radiation Protection Dosimetry 99:237-240.
42. Wilson RR. 1946. Radiological use of fast protons. Radiology 47:487-491.
43. Wouters BG, Lam GKY, Oelfke U, Gardey K, Durand RE, Skarsgard LD. 1996. Measurements of relative biological effectiveness of the 70 MeV proton beam at TRIUMF using chinese hamster V79 cells and the high-precision cell sorter assay. Radiation Research 146:159-170.